News Daily News FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential L.A. McKeown December 06, 2022
News Conference News Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices L.A. McKeown November 18, 2022
News Conference News AHA 2022 SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint Todd Neale November 09, 2022
News Conference News AHA 2022 Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI L.A. McKeown November 07, 2022
News Conference News VIVA 2022 TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years L.A. McKeown November 03, 2022
News Daily News Risk of Radiation Low for Pregnant Operators When Precautions Taken Michael O'Riordan September 27, 2022
News Conference News TCT 2022 SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss Michael O'Riordan September 19, 2022
News Conference News TCT 2022 FLASH: More Data to Support Mechanical Thrombectomy in PE L.A. McKeown September 18, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Daily News IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document L.A. McKeown August 05, 2022
News Conference News TVT 2022 No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest Michael O'Riordan June 09, 2022
News Daily News Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy L.A. McKeown June 01, 2022
News Daily News Percutaneous Axillary Access: SCAI Calls for Best Practices Caitlin E. Cox April 20, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2022 Caitlin E. Cox April 01, 2022
News Daily News Skipping Low-Value Cardiovascular Care Could Save Billions: AHA Michael O'Riordan March 01, 2022
News Daily News HawkOne Directional Atherectomy System Recalled Due to Risk of Tip Breakage L.A. McKeown January 21, 2022
News Daily News FDA Safety Communication Updates Stance on Endologix AAA Grafts L.A. McKeown January 13, 2022